COVID-19 dynamics after a national immunization program in Israel Research Published on 2021-04-192022-10-05 Journal: Nature Medicine [Category] SARS, 임상, [키워드] age Analysis BNT162b2 vaccine collected conducted COVID-19 COVID-19 case decrease Effect Factors groups Hospitalization immunization individual initiated lockdown Ministry of Health National Older pandemic performed receive Retrospective analysis temporal dynamics the vaccine vaccination [DOI] 10.1038/s41591-021-01337-2 [Article Type] Research
Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19경증 COVID-19 성인을 대상으로 한 favipiravir의 다기관 무작위 이중 맹검 위약 대조 시험Article Published on 2021-04-142022-09-11 Journal: BMJ Open [Category] 임상, [키워드] 1:1 Affair approved blinded by mouth caused clinical clinical trials control group Coronavirus infection COVID-19 COVID-19 sample Cox proportional hazard regression decrease diagnosed disease onset double-blind double-blinded dropout rate Efficacy and safety Eligible participants Ethics evaluate the effect evaluated Evidence Favipiravir follow-up period followed by hazard ratio healthcare hypothesise Infectious diseases institutional review board intention to treat International King lack limit medication men Mild Ministry of Health mouth nonpregnant Novel coronavirus outbreak outcome participant Patient PCR PCR test peer-reviewed per day physician Placebo placebo-controlled trial positive potential therapy primary analysis population Primary outcome randomised Randomised trial recruit recruited registration number registry reported required Respiratory illness SARS-CoV-2 subject swab sample symptomatic patient Symptomatic patients the timing therapeutic agent Therapeutics therapy treat treated Treatment Virology virus virus clearance women [DOI] 10.1136/bmjopen-2020-047495 PMC 바로가기 [Article Type] Article
Downregulation of type III interferons in patients with severe COVID‐19Observational Study Published on 2021-04-132022-10-04 Journal: Journal of medical virology [Category] MERS, SARS, 바이오마커, 임상, [키워드] Admission alteration C‐reactive protein Characteristics chemokine conducted Coronavirus disease 2019 COVID‐19 COVID‐19 patient COVID‐19 patients COVID‐19 cytokine disease disease severity ferritin fibrinogen group hospital IFN‐lambda indicated Japan knowledge labor lactate dehydrogenase Mild Ministry of Health pathophysiology Patient Protein reduced SARS‐CoV‐2 serum serum cytokine severe group severity significantly higher significantly lower single center the disease the patient two groups type III interferon Welfare [DOI] 10.1002/jmv.26993 PMC 바로가기 [Article Type] Observational Study
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trialSARS-CoV-2 백신(비활성화, Vero 세포)의 효능과 안전성을 평가하기 위한 무작위 이중 맹검 위약 대조 임상 3상 시험: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Letter Published on 2021-04-132022-09-10 Journal: Trials [Category] MERS, SARS, 비임상, 임상, 치료기술, [키워드] 1:1 24 hour 24 hours 95% confidence interval Activation Active surveillance administration Administrative Personnel Adverse adverse event adverse events Adverse reaction Adverse reactions African green monkey age Algorithm Aluminium aluminium hydroxide anaphylaxis Antibody test Antibody titer Antigen Arm asplenia assigned assumed assumption Autoimmune baseline bleeding disorders Blinding blood product blood products blood sample Blood samples breastfeeding women breath carried Cell culture China chloride Clinical efficacy clinical trial code Cohort cohorts comparator consent form cooperation Corticosteroid Corticosteroids COVID-19 COVID-19 cases COVID-19 disease COVID-19 symptoms COVID-19 test criteria Critical CRO Data and Safety Monitoring Board Day development diary dihydrogen DIHYDROGEN PHOSPHATE disease disodium disodium hydrogen phosphate dissemination dose dose of vaccination double blind double-blind double-blind study Efficacy Efficacy and safety element eligible Endpoint enrolled enrolment ethics committee evaluate event excluded exclusion criteria expected Follow-up follow-up period Frequency Gender genders green monkey group groups healthcare Healthcare professional healthcare professionals higher risk HIV infection hospital Hospitalization hydrogen Hydrogen phosphate hydroxide hypersensitivity identity IgG level IgG levels IgG test immunogenicity Immunoglobulin immunoglobulins immunosuppressive immunosuppressive therapy inactivated Inactivated Vaccines incidence incidence rate include Inclusion individual information informed consent form initiated Interactive Web Response System intramuscular dose investigator IWRS IWRS system kidney knowledge Local local reactions management medical doctors medical emergency Ministry of Health mortality rates neutralizing antibody Neutralizing antibody titer Novel coronavirus number Nurses objective Omega Other participant PCR PCR positivity performed Phase III Clinical Trial phosphate Placebo placebo group placebo-controlled positive pregnancy test pregnant preparation primary efficacy endpoint professional proportion protocol randomised randomised controlled trial randomised placebo controlled trial randomization Randomized Randomly Reactions receive recorded regimens Registration reported response risk risk of infection RT-PCR RT-PCR test RT-PCR tests Safety Monitoring Board Sample size SARS-CoV-2 vaccine SARS-CoV-2 virus screened second dose secondary Secondary objectives Serious Adverse Event Serious Adverse Events seroconversion rate Seropositivity severity severity of COVID-19 shown Sinovac sodium Sodium chloride sodium dihydrogen phosphate Sponsor status study group Study protocol subject subject’ supplementary material Symptom symptomatic symptomatic case symptomatic cases System systemic adverse reaction the ethics committee the timing the vaccine therapy Treatment treatment arm Trial Turkey two-sided vaccinated groups vaccination Vaccine Vero Vero Cell Web website width with COVID-19 within 6 months [DOI] 10.1186/s13063-021-05180-1 PMC 바로가기 [Article Type] Letter
Under-Reporting of COVID-19 Cases Among Indigenous Peoples in Brazil: A New Expression of Old InequalitiesPsychiatry Published on 2021-04-122022-10-31 Journal: Frontiers in Psychiatry [Category] COVID-19, [키워드] accumulated activity Affect Alto Analysis average Brazil Brazilian Amazon calculated Care collected confirmed case contribute coordination correlation COVID-19 COVID-19 case Critical death deaths District epidemiological Ethnic groups General population Generalized GLM Government Health incidence increased the risk Indigenous health system Indigenous peoples inequalities inequality information land lethality rate Ministry of Health Model MONITOR Mortality mortality rate mortality rates National New organization Poisson regression recorded Registered representing reveal Rio Spread Surveillance the disease threat Under-reporting [DOI] 10.3389/fpsyt.2021.638359 PMC 바로가기 [Article Type] Psychiatry
Assessment of COVID-19 Pandemic in Nepal: A Lockdown Scenario AnalysisPublic Health Published on 2021-04-082022-10-31 Journal: Frontiers in Public Health [Category] COVID-19, MERS, [키워드] analyzed assessment chain challenges confirmed case coronavirus Coronavirus infection country COVID-19 death distribution fatality Government highest impacts India initiated International introduced Isolation Local lockdown Ministry of Health Nepal performed Population positive preventive measure public health quarantine reaction recorded reported resources risk RT-PCR RT-PCR test scenario spatial distribution analysis Spread virus [DOI] 10.3389/fpubh.2021.599280 PMC 바로가기 [Article Type] Public Health
Analysis of nationwide multimodal complex treatment and drug pump therapy in Parkinson’s disease in times of COVID-19 pandemic in GermanyShort communication Published on 2021-04-012022-10-05 Journal: Parkinsonism & Related Disorders [Category] 치료법, [키워드] Care Clinical characteristics complex conducted COVID-19 pandemic cross-sectional database Diagnosis disease Effect gel Germany Health services hospital hospitalized patient initial Inpatient intestinal maintain marker Ministry of Health Multimodal care pandemic Parkinson's Disease Patient patients receiving Result therapy Treatment [DOI] 10.1016/j.parkreldis.2021.03.006 [Article Type] Short communication
Effectiveness of a multidrug therapy consisting of Ivermectin, Azithromycin, Montelukast, and Acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico멕시코 틀락스칼라(Tlaxcala)의 외래 코로나19 환자에서 이버멕틴, 아지트로마이신, 몬테루카스트, 아세틸살리실산으로 구성된 다제 요법의 효과Article Published on 2021-04-012022-09-11 Journal: International Journal of Infectious Diseases [Category] SARS, 치료제, [키워드] Acetylsalicylic acid All participant All participants Ambulatory care attenuate Azithromycin Care clinical evaluation COVID-19 COVID-19 case COVID-19 cases death effective Effectiveness Endotheliitis Enrollment greater Hospitalization Hospitalized Ivermectin likelihood lower risk lung Mexico Ministry of Health Montelukast Prevent prevented risk SARS-CoV-2 systemic inflammation therapy thrombosis treated Treatment was performed [DOI] 10.1016/j.ijid.2021.02.014 PMC 바로가기 [Article Type] Article
Assessing critical gaps in COVID-19 testing capacity: the case of delayed results in EcuadorCOVID-19 테스트 용량의 심각한 격차 평가: 에콰도르에서 지연된 결과의 경우Research Article Published on 2021-04-012022-09-01 Journal: BMC Public Health [Category] MERS, SARS, 진단, [키워드] Assessing association average clinical care clinically collected contribute country COVID-19 COVID-19 cases COVID-19 testing Critical database death rate death rates Decision making Decision-making diagnostic diagnostic testing Diseases Ecuador Generalized linear model Health policy highest highlight individual inequality Infectious diseases information information management Laboratory limitation management Ministry of Health mitigate National physical processed processing reported resource Result RT-PCR testing Sample subsequent supplementary material Testing Vaccination strategies Vaccination strategy WHO’ [DOI] 10.1186/s12889-021-10715-x PMC 바로가기 [Article Type] Research Article
Assessment of COVID-19 Treatment containing both Hydroxychloroquine and Azithromycin: A natural clinical trialClinical Trial Published on 2021-04-012022-10-04 Journal: International journal of clinical practice [Category] SARS, 신약개발, 임상, [키워드] absence approved arrhythmia assessment Azithromycin Baghdad biochemical parameter changes in Chi-square clinical effectiveness clinical symptom clinical trial conducted COVID-19 critical condition discharged Dizziness Effectiveness HCQ healthcare hospital hospitalisation Hydroxychloroquine hypoglycemia Intervention Iraq itching lab management measure medication Ministry of Health moderate Most patient natural trial outcome measure Pain paired t-test Patient patients patients died positive RT-PCR post-intervention promote Prospective Study QT prolongation reduced regimen reported RT-PCR Safety safety profile severity Side effect significantly skin rash study period Symptom symptoms of COVID-19 the disease therapy treat Treatment Treatment protocol Trial vital signs were used without symptom [DOI] 10.1111/ijcp.13856 PMC 바로가기 [Article Type] Clinical Trial